Aravive Inc. is a clinical stage biopharmaceutical company focused on developing innovative therapies to target the tumor microenvironment. With a mission to improve the lives of cancer patients, Aravive is utilizing its proprietary technology platform to develop novel treatments for multiple types of cancer.